Annexin Pharmaceuticals AB
Records under this name other than the patents Annexin Pharmaceuticals AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 3 of 3 · Back to Annexin Pharmaceuticals AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,901,614 | Methods for treating restenosis using annexin A5 Lapsed on the fee record Ended Feb 27, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 27, 2026 | USPTO record |
| US 9,682,122 | Compounds and methods for the treatment of vascular disease Lapsed on the fee record Ended Jun 20, 2025 · USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | USPTO record |
| US 9,649,355 | Compounds and methods for the treatment of vascular disease Lapsed on the fee record Ended May 16, 2025 · USPTO record | Lapsed on the fee record | Ended May 16, 2025 | USPTO record |